Bristol-Myers Squibb
BMY
$65.16
Share price
-0.49%
Change (1 day)
-14.92%
Change (1 year)
Categories
Bristol-Myers Squibb (BMY) - Net assets
Net assets on the balance sheet as of March 2023 : $31.88 B
According to Bristol-Myers Squibb's latest financial reports the company has $31.88 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Bristol-Myers Squibb - Net assets on balance sheet (from 2001 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $31.11 B | -13.58% |
| 2021-12-31 | $36.00 B | -4.95% |
| 2020-12-31 | $37.88 B | -26.72% |
| 2019-12-31 | $51.69 B | 265.95% |
| 2018-12-31 | $14.12 B | 19.25% |
| 2017-12-31 | $11.84 B | -27.53% |
| 2016-12-31 | $16.34 B | 13.33% |
| 2015-12-31 | $14.42 B | -3.73% |
| 2014-12-31 | $14.98 B | -1.66% |
| 2013-12-31 | $15.23 B | 11.72% |
| 2012-12-31 | $13.63 B | -14.05% |
| 2011-12-31 | $15.86 B | 1.46% |
| 2010-12-31 | $15.63 B | 5.77% |
| 2009-12-31 | $14.78 B | 20.78% |
| 2008-12-31 | $12.24 B | 15.9% |
| 2007-12-31 | $10.56 B | 5.72% |
| 2006-12-31 | $9.99 B | -10.86% |
| 2005-12-31 | $11.20 B | 9.86% |
| 2004-12-31 | $10.20 B | 4.25% |
| 2003-12-31 | $9.78 B | 9.13% |
| 2002-12-31 | $8.96 B | -16.48% |
| 2001-12-31 | $10.73 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $76.80 B | 140.87% | 🇺🇸 USA |
 Novartis NVS | $52.14 B | 63.53% | 🇨🇭 Switzerland |
 Pfizer PFE | $95.91 B | 200.81% | 🇺🇸 USA |
 AbbVie ABBV | $17.28 B | -45.78% | 🇺🇸 USA |
 Eli Lilly LLY | $11.29 B | -64.58% | 🇺🇸 USA |
 Amgen AMGN | $5.34 B | -83.23% | 🇺🇸 USA |
 Sanofi SNY | $80.48 B | 152.42% | 🇫🇷 France |
 Biogen BIIB | $13.78 B | -56.76% | 🇺🇸 USA |
 Merck MRK | $46.05 B | 44.45% | 🇺🇸 USA |
 AstraZeneca AZN | $35.81 B | 12.31% | 🇬🇧 UK |